Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
Pandemics and Biosecurity
9JUN

Malaria surges fourfold on a French island

2 min read
09:58UTC

ECDC recorded 171 Plasmodium falciparum cases in Mayotte to 21 May, 63 of them locally acquired, a 4.2-fold rise that means the parasite is now circulating on the island.

ScienceDeveloping
Key takeaway

Sixty-three locally acquired cases show malaria establishing on Mayotte, not merely arriving with travellers.

ECDC recorded 171 cases of Plasmodium falciparum malaria in Mayotte, the French territory in the Indian Ocean, from January to 21 May, averaging 25 a week in weeks 18 to 20 against 6 a week the year before, a 4.2-fold rise concentrated in the southern municipalities 1. P. falciparum is the most lethal of the human malaria species, responsible for most malaria deaths worldwide. Mayotte sits administratively within France but inside the Indian Ocean malaria transmission zone, between Madagascar and the Mozambique coast.

Of the 171, 63 were autochthonous, locally acquired rather than imported, which means the parasite is circulating on the island and not merely arriving with travellers. ECDC rates onward transmission to mainland Europe as very low; the immediate risk sits with Mayotte's own population and with travellers, WHO are now sensibly advised to consider prophylaxis rather than treating it as over-cautious.

Mayotte borders the Comoros inside a known transmission zone, and the mosquito vector that carries the parasite thrives in warmer, wetter conditions that do not respect the line between an endemic Indian Ocean territory and the European mainland it belongs to. The 63 locally acquired cases matter for that reason: the longer-run signal is the parasite's range establishing on French soil, not the size of this season's count. ECDC ran the surge in its Week 23 bulletin beside a reassuring mpox clade I trend , the agency's early-warning layer catching a vector range shift while an established threat held flat.

Deep Analysis

In plain English

Mayotte is a small French-administered island in the Indian Ocean, near Madagascar. Malaria spreads through mosquito bites; Plasmodium falciparum, the most lethal of the five malaria species, caused all 171 cases recorded here from January to late May 2026. Sixty-three of those 171 cases were caught locally rather than brought in by travellers. What stands out is the speed: in three weeks in late April and early May, cases averaged 25 per week versus six per week in the same period the year before. ECDC says the risk of malaria spreading to mainland France is very low, but recommends travellers visiting Mayotte take anti-malaria medication.

Deep Analysis
Root Causes

Mayotte sits within the Indian Ocean malaria transmission zone alongside Comoros, which has endemic Plasmodium falciparum. The island has historically relied on a combination of indoor residual spraying, insecticide-treated nets, and chemoprophylaxis for at-risk groups, but its vector control budget is administered by France's Agence Régionale de Santé (ARS) Océan Indien, which coordinates across both Mayotte and Réunion.

The 4.2-fold surge in weeks 18-20 and its concentration in southern municipalities, particularly Chirongui, is consistent with a localised failure in vector control coverage , either a gap in spraying cycles, insecticide resistance in the Anopheles gambiae population, or increased mosquito breeding habitat from seasonal rainfall.

Mayotte also hosts a large migrant population from Comoros , one of the world's highest malaria-burden small island states , and documented irregular migration across the 70km Mozambique Channel strait creates ongoing re-introduction pressure that vector control alone cannot address without cross-border cooperation.

What could happen next?
  • Risk

    Mayotte's 4.2-fold surge in locally acquired P. falciparum cases in three weeks signals a potential breakdown in vector control coverage in southern municipalities, which will require emergency intervention from France's ARS Océan Indien to prevent the surge from establishing endemic local transmission.

First Reported In

Update #6 · Ebola outbreak gets an R0, and a fork

ECDC· 9 Jun 2026
Read original
Different Perspectives
World Health Organization
World Health Organization
WHO's DON606 recalibration to confirmed-only reporting gives the clean baseline the CDC model rests on, but the apparent fall from 1,040 to 534 carries misinterpretation risk WHO communications have not pre-empted. The PABS deadlock ahead of IGWG7 and continuing MBP134/remdesivir assessment without authorisation make WHO the body most able to accelerate the two decisions that could change the outbreak's trajectory.
European Union (ECDC)
European Union (ECDC)
ECDC's Week 23 CDTR tracked four simultaneous non-Ebola signals: the Dermatophilus congolensis novel-transmission cluster across France, Germany and Spain; a 4.2-fold malaria surge in Mayotte; the Salmonella ST2045 multi-country cluster; and two new Saudi MERS cases. The continental early-warning layer is carrying a full multi-pathogen picture while Bundibugyo dominates headlines.
Uganda
Uganda
Uganda's 19 confirmed cases are concentrated in Kampala and Wakiso, an urban cluster that applied the 2022 Sudan-ebolavirus playbook; the Bwera border laboratory shortens cross-border confirmation to same-day. Uganda's regulatory authority must co-sign before MBP134 or remdesivir can dose any patient.
Democratic Republic of the Congo
Democratic Republic of the Congo
Kinshasa shares Bundibugyo sequence data in real time with no treaty-guaranteed access to the vaccines that data informs, and its health minister called the US entry ban discriminatory while negotiating an early lift. DRC accounts for 515 of 534 confirmed cases and faces IS-controlled access blockades in Mambasa that health authorities cannot resolve.
United States (HHS/CDC)
United States (HHS/CDC)
HHS expanded the Ebola entry ban to green-card holders on 5 June, widening a restriction expiring around 17 June against WHO advice. The CDC simultaneously published the R0=2.51 modelling, the sharpest analytical contribution to the response, from a federal bench that holds the NIH and acting CDC director roles in one person.
Imperial College London / Cori and Ferguson
Imperial College London / Cori and Ferguson
Anne Cori and Neil Ferguson place the case-fatality ratio at 30 to 40 per cent and read the 6.8-to-1 suspected-to-confirmed ratio as evidence that the laboratory figure understates true lethality. Many people die before a swab reaches them.